Artemis Therapeutics Inc. (ATMS) Research

Artemis Therapeutics Inc. currently lacks substantial business operations. Situated in New York, New York, this company previously concentrated on developing pharmaceutical agents to prevent and treat severe and life-threatening infectious diseases. It is a subsidiary of Tonak Ltd.

Market snapshot

Symbol
ATMS
Price
$0.50
Day change
-73.65%
Market cap
$55.8M
P/E ratio
-21032.59x
52-week range
0.1121-4.5
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Alpha One Inc. (AOAO)
  • Focus Impact BH3 Acquisition Co (BHAC)
  • Clover Leaf Capital Corp. (CLOE)
  • Iris Acquisition Corp (IRAA)
  • James Maritime Holdings, Inc. (JMTM)
  • Kingswood Acquisition Corp. (KWAC)
  • Southport Acquisition Corporation (PORT)
  • Petrocorp Inc. (PTCP)

Recent insider activity

  • CITRON SHIMON — trade (0 shares) on 2022-06-30
  • CITRON SHIMON — trade (0 shares) on 2022-06-30
  • CITRON SHIMON — trade (32772000 shares) on 2022-06-30
  • CITRON SHIMON — trade (21848400 shares) on 2022-06-30
  • Dana David — trade (0 shares) on 2022-07-26

Open Artemis Therapeutics Inc. (ATMS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.